TARIQ SHAFI to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications TARIQ SHAFI has written about Diabetes Mellitus, Type 2.
Connection Strength
0.964
-
Assessment of glycemia in chronic kidney disease. BMC Med. 2022 04 13; 20(1):117.
Score: 0.346
-
Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008 Dec; 52(6):1022-9.
Score: 0.136
-
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
Score: 0.112
-
Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes. J Am Soc Nephrol. 2025 Oct 01; 36(10):2061-2076.
Score: 0.107
-
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease? Curr Hypertens Rep. 2024 Dec; 26(12):463-474.
Score: 0.101
-
Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.
Score: 0.077
-
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2011 May; 93(5):1087-91.
Score: 0.040
-
Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2010 Oct 25; 170(19):1745-51.
Score: 0.039
-
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S92-8.
Score: 0.006